Activation of the Growth-Differentiation Factor 11 Gene by the Histone Deacetylase (HDAC) Inhibitor Trichostatin A and Repression by HDAC3

REFERENCES

• Agalioti, T., Chen G., and Thanos D.. 2002. Deciphering the transcriptional histone acetylation code for a human gene. Cell 111:381–392.
   PubMed Web of Science ®Google Scholar
• Armand, A. S., Della Gaspera B., Launay T., Charbonnier F., Gallien C. L., and Chanoine C.. 2003. Expression and neural control of follistatin versus myostatin genes during regeneration of mouse soleus. Dev. Dyn. 227:256–265.
   PubMedGoogle Scholar
• Boyd, K. E., and Farnham P. J.. 1999. Coexamination of site-specific transcription factor binding and promoter activity in living cells. Mol. Cell. Biol. 19:8393–8399.
   PubMedGoogle Scholar
• Butler, L. M., Zhou X., Xu W. S., Scher H. I., Rifkind R. A., Marks P. A., and Richon V. M.. 2002. The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc. Natl. Acad. Sci. USA 99:11700–11705.
   PubMed Web of Science ®Google Scholar
• Carmen, A. A., Rundlett S. E., and Grunstein M.. 1996. HDA1 and HDA3 are components of a yeast histone deacetylase (HDA) complex. J. Biol. Chem. 271:15837–15844.
   PubMedGoogle Scholar
• Darkin-Rattray, S. J., Gurnett A. M., Myers R. W., Dulski P. M., Crumley T. M., Allocco J. J., Cannova C., Meinke P. T., Colletti S. L., Bednarek M. A., Singh S. B., Goetz M. A., Dombrowski A. W., Polishook J. D., and Schmatz D. M.. 1996. Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase. Proc. Natl. Acad. Sci. USA 93:13143–13147.
   PubMed Web of Science ®Google Scholar
• Della Ragione, F., Criniti V., Della Pietra V., Borriello A., Oliva A., Indaco S., Yamamoto T., and Zappia V.. 2001. Genes modulated by histone acetylation as new effectors of butyrate activity. FEBS Lett. 499:199–204.
   PubMed Web of Science ®Google Scholar
• Eickhoff, B., Germeroth L., Stahl C., Kohler G., Ruller S., Schlaak M., and van der Bosch J.. 2000. Trichostatin A-mediated regulation of gene expression and protein kinase activities: reprogramming tumor cells for ribotoxic stress-induced apoptosis. Biol. Chem. 381:1127–1132.
   PubMed Web of Science ®Google Scholar
• Esquela, A. F., and Lee S. J.. 2003. Regulation of metanephric kidney development by growth/differentiation factor 11. Dev. Biol. 257:356–370.
   PubMedGoogle Scholar
• Fischle, W., Dequiedt F., Fillion M., Hendzel M. J., Voelter W., and Verdin E.. 2001. Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo. J. Biol. Chem. 276:35826–35835.
   PubMed Web of Science ®Google Scholar
• Fischle, W., Wang Y., and Allis C. D.. 2003. Histone and chromatin cross-talk. Curr. Opin. Cell Biol. 15:172–183.
   PubMed Web of Science ®Google Scholar
• Gamer, L. W., Cox K. A., Small C., and Rosen V.. 2001. Gdf11 is a negative regulator of chondrogenesis and myogenesis in the developing chick limb. Dev. Biol. 229:407–420.
   PubMed Web of Science ®Google Scholar
• Gamer, L. W., Wolfman N. M., Celeste A. J., Hattersley G., Hewick R., and Rosen V.. 1999. A novel BMP expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm inducer in Xenopus embryos. Dev. Biol. 208:222–232.
   PubMed Web of Science ®Google Scholar
• Ghoshal, K., Datta J., Majumder S., Bai S., Dong X., Parthun M., and Samson J. T.. 2002. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure. Mol. Cell. Biol. 22:8302–8319.
   PubMed Web of Science ®Google Scholar
• Glaser, K. B., Staver M. J., Waring J. F., Stender J., Ulrich R. G., and Davidsen S. K.. 2003. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Mol. Cancer Ther. 2:151–163.
   PubMed Web of Science ®Google Scholar
• Grozinger, C. M., Hassig C. A., and Schreiber S. L.. 1999. Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc. Natl. Acad. Sci. USA 96:4868–4873.
   PubMed Web of Science ®Google Scholar
• Guardiola, A. R., and Yao T. P.. 2002. Molecular cloning and characterization of a novel histone deacetylase HDAC10. J. Biol. Chem. 277:3350–3356.
   PubMed Web of Science ®Google Scholar
• Guenther, M. G., Lane W. S., Fischle W., Verdin E., Lazar M. A., and Shiekhattar R.. 2000. A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40- repeat protein linked to deafness. Genes Dev. 14:1048–1057.
   PubMed Web of Science ®Google Scholar
• Gui, C. Y., Ngo L., Xu W. S., Richon V. M., and Marks P. A.. 2004. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. Proc. Natl. Acad. Sci. USA 101:1241–1246.
   PubMed Web of Science ®Google Scholar
• He, L. Z., Tolentino T., Grayson P., Zhong S., Warrell R. P., Jr., Rifkind R. A., Marks P. A., Richon V. M., and Pandolfi P. P.. 2001. Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. J. Clin. Investig. 108:1321–1330.
   PubMed Web of Science ®Google Scholar
• Hirose, T., Sowa Y., Takahashi S., Saito S., Yasuda C., Shindo N., Furuichi K., and Sakai T.. 2003. p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. Oncogene 22:7762–7773.
   PubMed Web of Science ®Google Scholar
• Hou, M., Wang X., Popov N., Zhang A., Zhao X., Zhou R., Zetterberg A., Bjorkholm M., Henriksson M., Gruber A., and Xu D.. 2002. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. Exp. Cell Res. 274:25–34.
   PubMed Web of Science ®Google Scholar
• Ishizuka, T., and Lazar M. A.. 2003. The N-CoR/histone deacetylase 3 complex is required for repression by thyroid hormone receptor. Mol. Cell. Biol. 23:5122–5131.
   PubMedGoogle Scholar
• Jin, S., and Scotto K. W.. 1998. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol. Cell. Biol. 18:4377–4384.
   PubMed Web of Science ®Google Scholar
• Jin, S., Gorfajn B., Faircloth G., and Scotto K. W.. 2000. Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation. Proc. Natl. Acad. Sci. USA 97:6775–6779.
   PubMed Web of Science ®Google Scholar
• Johnstone, R. W. 2002. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 1:287–299.
   PubMed Web of Science ®Google Scholar
• Johnstone, R. W., and Licht J. D.. 2003. Histone deacetylase inhibitors in cancer therapy: is transcription the primary target? Cancer Cell. 4:13–18.
   PubMed Web of Science ®Google Scholar
• Kao, H. Y., Downes M., Ordentlich P., and Evans R. M.. 2000. Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev. 14:55–66.
   PubMed Web of Science ®Google Scholar
• Kim, H. S., Park J. S., Hong S. J., Woo M. S., Kim S. Y., and Kim K. S.. 2003. Regulation of the tyrosine hydroxylase gene promoter by histone deacetylase inhibitors. Biochem. Biophys. Res. Commun. 312:950–957.
   PubMedGoogle Scholar
• Koeller, K. M., Haggarty S. J., Perkins B. D., Leykin I., Wong J. C., Kao M. C., and Schreiber S. L.. 2003. Chemical genetic modifier screens. Small molecule trichostatin suppressors as probes of intracellular histone and tubulin acetylation. Chem. Biol. 10:397–410.
   PubMed Web of Science ®Google Scholar
• Laherty, C. D., Yang W. M., Sun J. M., Davie J. R., Seto E., and Eisenman R. N.. 1997. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89:349–356.
   PubMed Web of Science ®Google Scholar
• Lee, H., Lee S., Baek M., Kim H.-Y., and Jeoung D.-I.. 2002. Expression profile analysis of trichostatin A in human gastric cancer cells. Biotechnol. Lett. 24:377–381.
   Web of Science ®Google Scholar
• Li, J., Wang J., Nawaz Z., Liu J. M., Qin J., and Wong J.. 2000. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 19:4342–4350.
   PubMed Web of Science ®Google Scholar
• Lin, S. Y., Morrison J. R., Phillips D. J., and de Kretser D. M.. 2003. Regulation of ovarian function by the TGF-beta superfamily and follistatin. Reproduction 126:133–148.
   PubMed Web of Science ®Google Scholar
• Luo, W., and Skalnik D. G.. 1996. CCAAT displacement protein competes with multiple transcriptional activators for binding to four sites in the proximal gp91phox promoter. J. Biol. Chem. 271:18203–18210.
   PubMedGoogle Scholar
• Marks, P. A., Miller T., and Richon V. M.. 2003. Histone deacetylases. Curr. Opin. Pharmacol. 3:344–351.
   PubMed Web of Science ®Google Scholar
• Marks, P. A., Richon V. M., Breslow R., and Rifkind R. A.. 2001. Histone deacetylase inhibitors as new cancer drugs. Curr. Opin. Oncol. 13:477–483.
   PubMed Web of Science ®Google Scholar
• Marks, P. A., Richon V. M., and Rifkind R. A.. 2000. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J. Natl. Cancer Inst. 92:1210–1216.
   PubMed Web of Science ®Google Scholar
• Marks, P. A., Rifkind R. A., Richon V. M., and Breslow R.. 2001. Inhibitors of histone deacetylase are potentially effective anticancer agents. Clin. Cancer Res. 7:759–760.
   PubMed Web of Science ®Google Scholar
• Marks, P. A., Rifkind R. A., Richon V. M., Breslow R., Miller T., and Kelly W. K.. 2001. Histone deacetylases and cancer: causes and therapies. Nat. Rev. Cancer 1:194–202.
   PubMed Web of Science ®Google Scholar
• Matzuk, M. M., Lu N., Vogel H., Sellheyer K., Roop D. R., and Bradley A.. 1995. Multiple defects and perinatal death in mice deficient in follistatin. Nature 374:360–363.
   PubMed Web of Science ®Google Scholar
• McPherron, A. C., Lawler A. M., and Lee S. J.. 1999. Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nat. Genet. 22:260–264.
   PubMed Web of Science ®Google Scholar
• McPherron, A. C., Lawler A. M., and Lee S. J.. 1997. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387:83–90.
   PubMed Web of Science ®Google Scholar
• Neufeld, E. J., Skalnik D. G., Lievens P. M., and Orkin S. H.. 1992. Human CCAAT displacement protein is homologous to the Drosophila homeoprotein, cut. Nat. Genet. 1:50–55.
   PubMedGoogle Scholar
• Oh, S. P., Yeo C. Y., Lee Y., Schrewe H., Whitman M., and Li E.. 2002. Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning. Genes Dev. 16:2749–2754.
   PubMedGoogle Scholar
• Park, S. H., Lee S. R., Kim B. C., Cho E. A., Patel S. P., Kang H. B., Sausville E. A., Nakanishi O., Trepel J. B., Lee B. I., and Kim S. J.. 2002. Transcriptional regulation of the transforming growth factor beta type II receptor gene by histone acetyltransferase and deacetylase is mediated by NF-Y in human breast cancer cells. J. Biol. Chem. 277:5168–5174.
   PubMed Web of Science ®Google Scholar
• Richon, V. M., Sandhoff T. W., Rifkind R. A., and Marks P. A.. 2000. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc. Natl. Acad. Sci. USA 97:10014–10019.
   PubMed Web of Science ®Google Scholar
• Sambucetti, L. C., Fischer D. D., Zabludoff S., Kwon P. O., Chamberlin H., Trogani N., Xu H., and Cohen D.. 1999. Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects. J. Biol. Chem. 274:34940–34947.
   PubMed Web of Science ®Google Scholar
• Schuettengruber, B., Simboeck E., Khier H., and Seiser C.. 2003. Autoregulation of mouse histone deacetylase 1 expression. Mol. Cell. Biol. 23:6993–7004.
   PubMed Web of Science ®Google Scholar
• Shang, Y., Hu X., DiRenzo J., Lazar M. A., and Brown M.. 2000. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843–852.
   PubMed Web of Science ®Google Scholar
• Sowa, Y., Orita T., Minamikawa S., Nakano K., Mizuno T., Nomura H., and Sakai T.. 1997. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Biochem. Biophys. Res. Commun. 241:142–150.
   PubMed Web of Science ®Google Scholar
• Steffan, J. S., Bodai L., Pallos J., Poelman M., McCampbell A., Apostol B. L., Kazantsev A., Schmidt E., Zhu Y. Z., Greenwald M., Kurokawa R., Housman D. E., Jackson G. R., Marsh J. L., and Thompson L. M.. 2001. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413:739–743.
   PubMed Web of Science ®Google Scholar
• Sui, G., Soohoo C., Affar el B., Gay F., Shi Y., Forrester W. C., and Shi Y.. 2002. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA 99:5515–5520.
   PubMed Web of Science ®Google Scholar
• Taunton, J., Hassig C. A., and Schreiber S. L.. 1996. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272:408–411.
   PubMed Web of Science ®Google Scholar
• Tsuji, N., Kobayashi M., Nagashima K., Wakisaka Y., and Koizumi K.. 1976. A new antifungal antibiotic, trichostatin. J. Antibiot. 29:1–6.
   PubMed Web of Science ®Google Scholar
• Urnov, F. D., Yee J., Sachs L., Collingwood T. N., Bauer A., Beug H., Shi Y. B., and Wolffe A. P.. 2000. Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway. EMBO J. 19:4074–4090.
   PubMedGoogle Scholar
• Valarche, I., Tissier-Seta J. P., Hirsch M. R., Martinez S., Goridis C., and Brunet J. F.. 1993. The mouse homeodomain protein Phox2 regulates Ncam promoter activity in concert with Cux/CDP and is a putative determinant of neurotransmitter phenotype. Development 119:881–896.
   PubMedGoogle Scholar
• Van Lint, C., Emiliani S., and Verdin E.. 1996. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr. 5:245–253.
   PubMed Web of Science ®Google Scholar
• Vaziri, C., Stice L., and Faller D. V.. 1998. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals. Cell Growth Differ. 9:465–474.
   PubMedGoogle Scholar
• Wang, A., Kurdistani S. K., and Grunstein M.. 2002. Requirement of Hos2 histone deacetylase for gene activity in yeast. Science 298:1412–1414.
   PubMed Web of Science ®Google Scholar
• Wang, S., Yan-Neale Y., Fischer D., Zeremski M., Cai R., Zhu J., Asselbergs F., Hampton G., and Cohen D.. 2003. Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line. Oncogene 22:6204–6213.
   PubMed Web of Science ®Google Scholar
• Wen, Y. D., Cress W. D., Roy A. L., and Seto E.. 2003. Histone deacetylase 3 binds to and regulates the multifunctional transcription factor TFII-I. J. Biol. Chem. 278:1841–1847.
   PubMedGoogle Scholar
• Wen, Y. D., Perissi V., Staszewski L. M., Yang W. M., Krones A., Glass C. K., Rosenfeld M. G., and Seto E.. 2000. The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc. Natl. Acad. Sci. USA 97:7202–7207.
   PubMed Web of Science ®Google Scholar
• Wharton, W., Savell J., Cress W. D., Seto E., and Pledger W. J.. 2000. Inhibition of mitogenesis in Balb/c-3T3 cells by trichostatin A. Multiple alterations in the induction and activation of cyclin-cyclin-dependent kinase complexes. J. Biol. Chem. 275:33981–33987.
   PubMedGoogle Scholar
• Wu, H. H., Ivkovic S., Murray R. C., Jaramillo S., Lyons K. M., Johnson J. E., and Calof A. L.. 2003. Autoregulation of neurogenesis by GDF11. Neuron 37:197–207.
   PubMed Web of Science ®Google Scholar
• Xiao, H., Hasegawa T., and Isobe K.. 1999. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells. J. Cell. Biochem. 73:291–302.
   PubMed Web of Science ®Google Scholar
• Yoshida, M., and Beppu T.. 1988. Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A. Exp. Cell Res. 177:122–131.
   PubMed Web of Science ®Google Scholar
• Yoshida, M., Furumai R., Nishiyama M., Komatsu Y., Nishino N., and Horinouchi S.. 2001. Histone deacetylase as a new target for cancer chemotherapy. Cancer Chemother. Pharmacol. 48:S20–S26.
   PubMed Web of Science ®Google Scholar
• Yoshida, M., Horinouchi S., and Beppu T.. 1995. Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17:423–430.
   PubMed Web of Science ®Google Scholar
• Yoshida, M., Kijima M., Akita M., and Beppu T.. 1990. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265:17174–17179.
   PubMed Web of Science ®Google Scholar
• Zhou, X., Marks P. A., Rifkind R. A., and Richon V. M.. 2001. Cloning and characterization of a histone deacetylase, HDAC9. Proc. Natl. Acad. Sci. USA 98:10572–10577.
   PubMed Web of Science ®Google Scholar